SCHEMBL6630822

SCHEMBL6630822

C[N+]1(C2CCN(c3nc4cccc5c4n3CCC5=O)CC2)CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.34
L3MBTL3 Q96JM7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KCNH2 Q12809 3/20 0.32
GRM2 Q14416 3/20 0.32
HTR3A P46098 2/20 0.32
EBP Q15125 1/20 0.32
DHCR7 Q9UBM7 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
DPP4 P27487 1/20 0.31
CRHR1 P34998 1/20 0.30
CYP2D6 P10635 1/20 0.30
CHRM1 P11229 1/20 0.30
HRH1 P35367 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6508148 0.99 PARP1 (0.36) PARP1L3MBTL3L3MBTL1KCNH2GRM2
SCHEMBL7257136 0.81 OPRM1 (0.37) PARP1KCNH2GRM2HTR3A
SCHEMBL6633308 0.80 HRH1 (0.43) PARP1KCNH2GRM2HTR3ACRHR1
SCHEMBL6508880 0.80 CCR4 (0.39) PARP1L3MBTL3L3MBTL1CYP2D6HRH1
SCHEMBL7257145 0.78 KCNH2 (0.37) PARP1KCNH2GRM2HTR3AALDH1A1
SCHEMBL7257413 0.78 PARP1 (0.36) PARP1KCNH2GRM2HTR3ACRHR1
SCHEMBL7257414 0.76 KCNH2 (0.39) PARP1KCNH2GRM2HTR3A
SCHEMBL6630805 0.76 PARP1 (0.43) PARP1HTR3AKDM4EALDH1A1
SCHEMBL6631361 0.75 HDAC6 (0.46) PARP1KCNH2GRM2KDM4EALDH1A1
SCHEMBL7262852 0.75 MAPK1 (0.33) PARP1L3MBTL1KCNH2GRM2HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309594-B1 BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2004-12-15 EP claimed
EP-1309594-B1 BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2004-12-15 EP disclosed
EP-1389194-A2 INHIBITORS OF BACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-02-18 EP disclosed
WO-2002088101-A2 INHIBITORS OF BACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed